- ICH GCP
- US Clinical Trials Registry
- Researchers
- Netherlands
- Breast Neoplasms
Medical specialists from Netherlands tagged as investigators in clinical trials studying Breast Neoplasms
Total 147 results
-
C.W. Menke-van der Houven van Oordt, MD, PhDSeen in:
- Noord-Holland, Amsterdam, AmsterdamUMC
Trials:- NCT05955833 (Principal Investigator)
-
Carmen van de Pol, MDSeen in:
- Leiderdorp, Alrijne Ziekenhuis
Trials:- NCT02839863 (Principal Investigator)
Conditions: -
Cécile de Monyé, MD, PhDSeen in:
- Rotterdam, Erasmus Medical Center
Trials:- NCT03374826 (Principal Investigator)
Conditions: -
D de Gooyer, MDSeen in:
- Roosendaal, Bravis Ziekenhuis
Trials:- NCT01898117 (Principal Investigator)
Conditions: -
D F Kehrer, MDSeen in:
- Capelle Aan Den IJssel, IJsselland ziekenhuis
Trials:- NCT01898117 (Principal Investigator)
Conditions: -
D Houtsma, MDSeen in:
- Den Haag, Haga
Trials:- NCT01898117 (Principal Investigator)
Conditions: -
D. Ten Bokkel HuininkSeen in:
- Bilthoven, Alexander Monro Ziekenhuis
Trials:- NCT05503108 (Principal Investigator)
-
Daan Brandenbarg, PhDSeen in:
- Groningen, University Medical Center Groningen
Trials:- NCT05851053 (Principal Investigator)
Conditions: -
Daan ten Bokkel HuininkSeen in:
- Bilthoven, Alexander Monro Ziekenhuis
Trials:- NCT05514054 (Principal Investigator)
Conditions: -
Danny A Young-Afat, MDSeen in:
- Utrecht, University Medical Center Utrecht
Trials:- NCT02839863 (Sub-Investigator)
Conditions: -
Danny Evers, MD PhDSeen in:
- Almelo, Ziekenhuisgroep Twente
Trials:- NCT02839863 (Principal Investigator)
Conditions: -
Danny HoutsmaSeen in:
- Zuid-Holland, Den Haag, Haga Ziekenhuis locatie Leyweg
Trials:- NCT04975308 (Principal Investigator)
- NCT05514054 (Principal Investigator)
Conditions: -
Dieuwke Mink van der Molen, PhDSeen in:
- Utrecht, University Medical Center Utrecht
Trials:- NCT02839863 (Sub-Investigator)
Conditions: -
E Kerver, MDSeen in:
- Amsterdam, OLVG
Trials:- NCT01898117 (Principal Investigator)
Conditions: -
E Kuip, MDSeen in:
- NIjmegen, Radboud UMC
Trials:- NCT02810743 (Principal Investigator)
Conditions: -
E van der Wall, MDSeen in:
- Utrecht, University Medical Center Utrecht
Trials:- NCT02810743 (Principal Investigator)
Conditions: -
Eline BoonSeen in:
- Other, Venlo, VieCuri Medisch Centrum
Trials:- NCT05132582 (Principal Investigator)
Conditions: -
Ester SiemerinkSeen in:
- Overijssel, Hengelo, Ziekenhuisgroep Twente, locatie Almelo
Trials:- NCT05514054 (Principal Investigator)
Conditions: -
Esther BoumanSeen in:
- Other, Doedrecht, Albert Schweitzer Hospital
Trials:- NCT05132582 (Principal Investigator)
Conditions: -
Esther Bouman-WammesSeen in:
- Zuid-Holland, Dordrecht, Albert Schweitzer Ziekenhuis, locatie Dordwijk
Trials:- NCT05514054 (Principal Investigator)
Conditions: -
Esther Broekman, MDSeen in:
- Groningen, University Medical Center Groningen
Trials:- NCT05949424 (Principal Investigator)
-
F E de Jong, MDSeen in:
- Rotterdam, Ikazia
Trials:- NCT01898117 (Principal Investigator)
Conditions: -
F Erdkamp, MDSeen in:
- Sittard, Zuyderland
Trials:- NCT01898117 (Principal Investigator)
Conditions: -
F.A.J. ToonenSeen in:
- Leiderdorp, Alrijne Ziekenhuis
Trials:- NCT05503108 (Principal Investigator)
-
G Sonke, MDSeen in:
- Amsterdam, Antoni van Leeuwenhoek
Trials:- NCT05301881 (Principal Investigator)
- NCT03126812 (Principal Investigator)
-
G.J. VeldhuisSeen in:
- Nieuwegein, Sint Antonius Ziekenhuis
Trials:- NCT05503108 (Principal Investigator)
-
Gabe S SonkeSeen in:
- Other, Amsterdam, Netherlands Cancer Institute
Trials:- NCT05132582 (Principal Investigator)
Conditions: -
Geertruida H de Bock, Prof. dr.Seen in:
- Groningen, University Medical Center Groningen
Trials:- NCT05851053 (Principal Investigator)
Conditions: -
Geke A.P. Hospers, MD,PhDSeen in:
- Groningen, UMCG
Trials:- NCT05156606 (Principal Investigator)
Conditions: -
H de Graaf, MDSeen in:
- Leeuwarden, MCL
Trials:- NCT01898117 (Principal Investigator)
Conditions:
Clinical Trials on Breast Neoplasms
-
Seagen Inc.CompletedTriple Negative Breast Neoplasms | Hormone Receptor Positive Breast Neoplasms | HER2 Positive Breast Neoplasms | HER2 Mutations Breast NeoplasmsUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Celgene CorporationTerminatedInflammatory Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Recurrent Breast Cancer | HER2-negative Breast CancerUnited States
-
Dana-Farber Cancer InstituteConquer Cancer FoundationRecruitingBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Inflammatory Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of BreastUnited States
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Spain, Israel, Canada, Belgium, United Kingdom, France, Tunisia
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Canada, Germany, Spain, Taiwan, Belgium, Philippines, Israel, Hong Kong, Thailand, Pakistan, Russian Federation, Italy, Romania, China, France, Peru, United Kingdom, Czech Republic, Australia, Chile, Korea, Republic of and more
-
Innocrin PharmaceuticalCompletedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Male Breast Cancer | ER+ Breast Cancer | Cancer of the BreastUnited States
-
Oslo University HospitalKarolinska Institutet; Hoffmann-La Roche; Rigshospitalet, Denmark; Helse Stavanger... and other collaboratorsCompletedTriple Negative Breast Cancer | Cancer, BreastNorway, Denmark
-
MedSIRHoffmann-La RocheCompletedAdvanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast CancerSpain, France, United Kingdom, Germany, Italy
-
Centro Hospitalar Lisboa OcidentalInstituto Nacional de Medicina Legal e Ciências Forenses, Delegação do SulUnknownMale Breast Cancer | Female Breast Cancer
-
G1 Therapeutics, Inc.TerminatedBreast Cancer | Breast Neoplasm | Triple-Negative Breast Cancer | Triple-Negative Breast NeoplasmsUnited States, Bulgaria, Croatia, Slovenia, Serbia, Belgium, North Macedonia, Slovakia